Evidence map›Paper›PMID 42040427›Full record

ArticleACS omega2026

Solubility and Crystal Shape of Vonoprazan Fumarate in Monosolvents and Cosolvent Mixtures.

Hongcheng Li, Xinyue Qiu, Yan Wang, Jinting Yuan, Fumin Xue, Xiaohui Li

Abstract read
In one paragraph

Article in ACS omega, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Hongcheng LiDepartment of Pharmacology, Xiangya School of Pharmaceutical Sciences, Central South University, Changsha 410013, China.
Xinyue QiuSchool of Pharmaceutical Sciences, Shandong Analysis and Test Center, Qilu University of Technology (Shandong Academy of Sciences), Jinan 250014, China.
Yan WangSchool of Pharmaceutical Sciences, Shandong Analysis and Test Center, Qilu University of Technology (Shandong Academy of Sciences), Jinan 250014, China.
Jinting YuanShouguang Fukang Pharmaceutical Co., Ltd., Shouguang 262700, China.
Fumin XueSchool of Pharmaceutical Sciences, Shandong Analysis and Test Center, Qilu University of Technology (Shandong Academy of Sciences), Jinan 250014, China.ORCID https://orcid.org/0000-0002-8097-0108
Xiaohui LiDepartment of Pharmacology, Xiangya School of Pharmaceutical Sciences, Central South University, Changsha 410013, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Vonoprazan fumarate (VPF) is a novel potassium-competitive acid blocker that exhibits superior acid suppression compared to proton pump inhibitors. The solubility of VPF in water, methanol, ethanol, dimethylformamide, and mixed solvents of water + acetonitrile, water + acetone, methanol + acetone, and ethanol + acetonitrile was determined by a gravimetric method within the temperature range of 283.15-333.15 K under atmospheric pressure. The solubility data of VPF are positively related to the temperature in all selected solvents. In pure solvents, the solubility of VPF follows the order of DMF > methanol > ethanol > water. In the four cosolvent mixtures, the maximum solubility effect occurred as the solvent composition changed. The maximum values can be observed at

Identifiers

PMID42040427
PMCPMC13103789

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.